Julia Matas

ORCID: 0009-0004-6041-2995
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • CRISPR and Genetic Engineering
  • Colorectal and Anal Carcinomas
  • Evolution and Genetic Dynamics
  • Colorectal Cancer Screening and Detection
  • Colorectal Cancer Treatments and Studies

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
2021-2022

University of Washington
2021-2022

Seattle University
2021

Although somatic mutations in colorectal cancer are well characterized, little is known about the accumulation of normal colon before cancer. Here, we have developed and applied an ultrasensitive, single-molecule mutational test based on CRISPR-DS technology, which enables mutation detection at extremely low frequency (<0.001) from patients with without This testing platform revealed that carries common genes, but these more abundant Oncogenic KRAS were observed one third none Patients also...

10.1158/0008-5472.can-21-3607 article EN Cancer Research 2022-02-16

ABSTRACT While somatic mutations in colorectal cancer (CRC) are well characterized, little is known about the accumulation of normal colon prior to cancer. Here we have developed and applied an ultra-sensitive, single-molecule mutational test based on CRISPR-DS technology, which enables mutation detection at extremely low frequency (&lt;0.001) from patients with without CRC. We found oncogenic KRAS one third CRC but none Patients also carried more TP53 than cancer, these were pathogenic...

10.1101/2021.10.11.21264780 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-10-14

&lt;div&gt;Abstract&lt;p&gt;Although somatic mutations in colorectal cancer are well characterized, little is known about the accumulation of normal colon before cancer. Here, we have developed and applied an ultrasensitive, single-molecule mutational test based on CRISPR-DS technology, which enables mutation detection at extremely low frequency (&lt;0.001) from patients with without This testing platform revealed that carries common genes, but these more abundant Oncogenic...

10.1158/0008-5472.c.6513700.v1 preprint EN 2023-03-31

&lt;div&gt;Abstract&lt;p&gt;Although somatic mutations in colorectal cancer are well characterized, little is known about the accumulation of normal colon before cancer. Here, we have developed and applied an ultrasensitive, single-molecule mutational test based on CRISPR-DS technology, which enables mutation detection at extremely low frequency (&lt;0.001) from patients with without This testing platform revealed that carries common genes, but these more abundant Oncogenic...

10.1158/0008-5472.c.6513700 preprint EN 2023-03-31
Coming Soon ...